Le Lézard
Classified in: Health
Subjects: NPT, PDT

ISPE Announces a New Sustainability Community of Practice


The International Society for Pharmaceutical Engineering (ISPE) has announced the launch of the ISPE Community of Practice (CoP) on Sustainability.

NORTH BETHESDA, Md., July 2, 2024 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced the launch of the ISPE Community of Practice (CoP) on Sustainability. The Sustainability CoP joins ISPE's 20 Global Technical CoPs and supports industry-wide efforts to reliably deliver quality medicines to people.

Governments around the world have made international commitments to reduce climate impact and protect nature. Policy frameworks have been established to facilitate and drive progress against agreed upon targets. These directly impact end-to-end activities for the biopharmaceutical, pharmaceutical, and medical device sectors, including research and development, manufacturing, commercial activities, and extended supply chains including logistics. The supplier base and contract development and manufacturing landscape are also heavily impacted, as both significantly affect the product footprint on environmental, social, and governance (ESG).

The new Sustainability CoP's mission is as follows:

The Sustainability CoP will be holistic, focusing on sustainability and responsibility in all facets across the product life cycle. These include:

"Environmental sustainability is vital for protecting the well-being of both people and the planet, ensuring a healthier future for generations to come. We believe that as a nonprofit and given the scope and caliber of its robust network of 22,000 members?, which includes pharmaceutical companies and their suppliers, ISPE is uniquely positioned to facilitate?one unified and aligned approach to help fulfill our industry-wide commitments to sustainability," said Ester Lovsin?Barle, Takeda, Chair of the new Sustainability CoP.?"With the addition of this new CoP, we plan to identify and bring forth best practices, define maturity levels, liaise with regulatory and law-making bodies, and communicate valuable lessons learned and case studies with relevant stakeholders ? all while maintaining focus on quality and safety."?

Members of Sustainability CoP will aim to bring forward solutions for the industry's unique challenges related to sustainability, gathering insights and engaging in data as well as knowledge-sharing with the pharmaceutical community. The new CoP offers members the opportunity to collaborate with 20 existing CoPs in the ISPE community to deliver solutions in the area of sustainability, leveraging existing resources such as the ISPE Baseline Guide Volume 6: Biomanufacturing Facilities (Third Edition) and exploring pertinent topics like the influence on reduction of energy consumption in facility design.

Existing ISPE members are invited to join the Sustainability CoP by selecting the Sustainability CoP in their ISPE profiles. To view the list of existing CoPs, visit ISPE.org/CoP. To become an ISPE member, visit ISPE.org/join.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 22,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

Media Contact

Katie LeChase, ISPE, 3607189771, [email protected], ISPE

SOURCE ISPE


These press releases may also interest you

at 20:00
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for 225Ac-FL-020, the company's lead radiopharmaceutical,...

at 19:30
Vitality Products Inc. (the "Company" or "Vitality"), a manufacturer, marketer and distributor of premium vitamins and supplements, is pleased to report its financial results for the first quarter ended April 30, 2024 and provide a business update....

at 18:05
Teva Pharmaceutical Industries Ltd. announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live...

at 18:05
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announced that it has closed a non-brokered private placement,...

at 18:00
Global technology2use company CHG-MERIDIAN continues its strong growth path in Australia and New Zealand (ANZ) with the acquisition of Maia Financial Pty Limited's (Maia Financial) asset portfolio on June...

at 17:45
The global load monitoring systems market size is estimated to grow by USD 820.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 4.34% during the forecast period. Increasing use of load monitoring...



News published on and distributed by: